Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer

Clinical trial NCT05101564 · COMPLETED

Trial details

NCT number: NCT05101564
Sponsor: Jennifer Lee Caswell-Jin
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER2-negative Breast Cancer ER Positive Breast Cancer

Start date: 2023-03-20
Primary completion: 2024-06-03
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.